Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Prazosin: biochemistry and structure-activity studies.

H J Hess

    Postgraduate Medicine
    |November 1, 1975
    PubMed
    Summary
    This summary is machine-generated.

    Prazosin effectively lowers blood pressure through direct vasodilation, primarily in arterioles, without significantly increasing heart rate. This novel antihypertensive agent demonstrates a high safety margin in animal studies.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Antiinflammatory and analgesic activity of CP-96,345: an orally active non-peptide substance P receptor antagonist.

    Regulatory peptides·1993
    Same author

    [Diphtheria in an infant].

    Padiatrie und Padologie·1993
    Same author

    Antiinflammatory and analgesic activity of a non-peptide substance P receptor antagonist.

    European journal of pharmacology·1992
    Same author

    Identification and structural characterization of alpha 1-adrenergic receptor subtypes.

    Molecular pharmacology·1990
    Same author

    Synthesis and characterization of arylamine derivatives of rauwolscine as molecular probes for alpha 2-adrenergic receptors.

    Hypertension (Dallas, Tex. : 1979)·1987
    Same author

    Photoaffinity labeling of the porcine brain alpha 2-adrenergic receptor using a radioiodinated arylazide derivative of rauwolscine: identification of the hormone-binding subunit.

    Proceedings of the National Academy of Sciences of the United States of America·1986
    Same journal

    Relationship of serum nesfatin-1 levels with body mass index and c-reactive protein in patients presenting to the emergency department with epileptic seizures.

    Postgraduate medicine·2026
    Same journal

    Clinical pharmacokinetics of colistimethate sodium and formed colistin in patients with renal impairment or on dialysis modalities: a systematic review and implications for precision dosing.

    Postgraduate medicine·2026
    Same journal

    The role of type D personality in pregnancy symptom severity, functional limitations, and maternal ambivalence.

    Postgraduate medicine·2026
    Same journal

    Operational and demographic predictors of leaving without being seen in a high-volume tertiary emergency department: a five-year case-control study.

    Postgraduate medicine·2026
    Same journal

    Risk of adverse effects of the concomitant use of statins with calcium channel blockers: a systematic review and meta-analysis.

    Postgraduate medicine·2026
    Same journal

    Association between frailty and major chronic disease-free life expectancy: a large community-based longitudinal study.

    Postgraduate medicine·2026
    See all related articles

    Area of Science:

    • Pharmacology
    • Cardiovascular Medicine
    • Biochemistry

    Background:

    • Prazosin is a novel antihypertensive agent developed through systematic synthesis and pharmacologic efforts.
    • The primary goal was to create an agent that lowers blood pressure via direct vasodilation.

    Purpose of the Study:

    • To elucidate the mechanism of action of prazosin as an antihypertensive agent.
    • To investigate the biochemical basis for prazosin's vasodilatory effects and its impact on heart rate.

    Main Methods:

    • Pharmacologic studies assessing vasodilator action and heart rate effects.
    • Biochemical assays using isolated cyclic nucleotide phosphodiesterases.
    • Tissue distribution studies with radioactive prazosin-2-14C.
    • Pharmacokinetic and biotransformation analyses.

    Related Experiment Videos

  • Safety evaluation studies in various animal species.

    • Main Results:

    • Prazosin's vasodilator action is primarily localized to arterioles, with minimal increase in heart rate.
    • Prazosin appears to increase intracellular cyclic AMP at vascular sites and cyclic GMP at cardiac cholinergic receptor sites.
    • Tissue distribution and pharmacokinetic studies support the proposed mechanism of action.
    • Prazosin exhibits a high margin of safety across multiple animal species.

    Conclusions:

    • Prazosin is a safe and effective antihypertensive agent with a unique mechanism of action.
    • Its therapeutic effects are mediated by modulating intracellular cyclic nucleotide levels in vascular and cardiac tissues.
    • Prazosin represents a significant advancement in the treatment of hypertension.